Biostar Technologies
Beijing · Founded 2002
About Biostar Technologies
Beijing Biostar Technologies, Ltd. was incorporated in Haidian Park, Zhongguancun Science and Technology Park, Beijing, in July 2002. The national high-tech led by the team of Chinese scientists in the United States led by Dr. Tang Li and Dr. Qiu Rongguo. The company, focusing on biomedical development, technology and transfer of anti-tumor small molecule chemical drugs, and technical service consulting, pioneered the creation of new anti-cancer drugs for epothilone in China, and its technology is at the international advanced level.
Company Facts
- Founded: 2002
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Total funding: $890.0M
- Funding stage: IPO
- Last round: Series E (Nov 2020)
- Ticker: hkg:2563
- Website: http://www.biostar-pharm.com/
- Phone: 010-56315388
Industries & Categories
Biotechnology, Life Science, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/biostar-technologies-1367 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.